『The PODdoctors with Dr. Dauphinee and Dr. Hussain』のカバーアート

The PODdoctors with Dr. Dauphinee and Dr. Hussain

The PODdoctors with Dr. Dauphinee and Dr. Hussain

著者： Dr. Damien Dauphinee and Dr. Raafae Hussain
無料で聴く

ThePODdoctors are Dr. Damien Dauphinee, double board certified in Reconstructive Foot and Ankle Surgery and Wound Management and his partner Dr. Raafae Hussain, fellowship trained podiatric surgeon. Each week ThePODdoctors will be discussing aspects of podiatric medicine and surgery to educate our audience on common foot and ankle problems and the latest treatment options available.Copyright 2020 All rights reserved. エクササイズ・フィットネス フィットネス・食生活・栄養 衛生・健康的な生活 身体的病い・疾患
エピソード
  • The Magic Trick in Peripheral Nerve Surgery: Tulavi's Allay Hydrogel Cap

    The Magic Trick in Peripheral Nerve Surgery: Tulavi's Allay Hydrogel Cap
    2026/04/17
    Episode Description: Dr. Damien Dauphinee sits down with Josh Vose, CEO of Tulavi Therapeutics, and Andrea Para, Senior Director of Medical Affairs and Strategy, to explore a breakthrough in peripheral nerve surgery. The conversation covers how the Allay Hydrogel Cap is transforming neuroma treatment with a sutureless, resorbable technology that delivers dramatic pain relief and puts advanced nerve care within reach of every surgeon.Key Takeaways:● The Allay Hydrogel Cap received de novo FDA classification in July 2024, representing a new category of in-situ forming nerve cap technology distinct from traditional biologic caps● In a retrospective multicenter analysis of 23 patients, no neuroma formation was observed in either prophylactic or therapeutic groups, with an average pain score reduction of 5.5 points● The sutureless application eliminates the need for microsurgery training, enabling general surgeons and non-fellowship-trained physicians to achieve outcomes previously limited to microsurgical specialists● Traditional neuroma treatments like TMR show only 50% pain reduction and 25% cure rates in revision cases, while early Allay results are demonstrating superior and more consistent outcomes● Patients are discontinuing opioids within days of surgery, a finding replicated across multiple surgical sites and a significant departure from typical post-neurectomy recovery● The hydrogel is 90% water, remains stable for three to four months past the neuroma formation window, and fully hydrolyzes within eight months, leaving no scarring or remnants● Surgeons should dissect back to normal, healthy nerve tissue before capping, and ensure adequate nerve length to position horizontally in the form for optimal gel application● The "unmasking phenomenon," where resolving dominant nerve pain reveals secondary musculoskeletal or nerve issues, is common and requires careful patient counseling and precise post-op pain assessment● Tulavi is expanding into TMR applications, pediatric use (patients over 25 kg), and has pipeline products targeting nerve repair expected in early to mid-2027Guest Info:Josh Vose, MD, MBACEO, Tulavi TherapeuticsBackground: Chemical engineer (Georgia Tech) turned surgeon-operator with 25+ years building peripheral nerve and surgical device startups. MD from the Medical College of Georgia in Augusta; general surgery training in Boston. Former CEO of Peak Surgical (Plasma Blade, acquired by Medtronic) and Sia (resorbable mesh for breast reconstruction, acquired by Integra). Joined Tulavi to commercialize the Allay Hydrogel Cap and scale peripheral nerve solutions beyond microsurgery-only centers.LinkedIn: https://www.linkedin.com/in/josh-vose-7306661Website: www.tulavi.comAndrea Para, PhDSenior Director of Medical Affairs and Strategy, Tulavi TherapeuticsBackground: Medtech strategist, patient advocate, and bioengineer with 14+ years across medtech R&D, hospital and medtech consulting, and strategic planning. BS, MS, and PhD in Bioengineering from Georgia Tech, where her doctoral thesis under Dr. David Ku focused on preventing rapid platelet accumulation under very high shear stress. Previously Director of Exploration at Edwards Lifesciences, Sr. Manager for Product Development and Strategy at Accenture, Consulting Director at Vizient, and R&D Engineer II at St. Jude Medical working on next-generation heart valves. Also Principal/CEO of Medivici LLC, providing technical due diligence for medical device and IVD investors. Joined Tulavi in November 2025.LinkedIn: https://www.linkedin.com/in/andrea-paraWebsite: www.tulavi.comResources:● "Saving Limbs, Saving Lives: Advanced Treatments to Prevent Amputations in Diabetic Populations" by Dr. Damien Dauphinee (Kindle): www.amazon.com● Tulavi Therapeutics: www.tulavi.com● Dr. Eddie Cobray's publication on first 11 patients with Allay Hydrogel Cap (published approximately four months before recording)● American Society of Peripheral Nerve (ASPN) abstract: retrospective multicenter analysis of 23 patients● Vizient Innovative Technology Contract: www.vizientinc.com● Association of Extremity Nerve Surgeons (AENS): www.aens.us● Incept (medtech accelerator, parent company family of Tulavi)● Gerson Lehrman Group (GLG): www.glg.itConnect:● The Pod Doctors: www.thepoddoctors.com● The Pod Doctors on Spotify, Apple Podcasts, Stitcher, and YouTube● Tulavi Therapeutics: www.tulavi.com● The Pod Doctors on Facebook and Twitter#ThePodDoctors #Podiatry #FootAndAnkle #PodiatricMedicine #WoundCare #DiabeticFootCare #PeripheralNerve #Neuroma #FootSurgery #LimbPreservation #TulaviTherapeutics #AllayHydrogelCap #NerveCap #PeripheralNerveSurgery #NeuromaTreatment #MedicalDevices #SurgicalInnovation #PainManagement #OpioidReduction #Neurectomy
    続きを読む 一部表示
    1 時間 1 分
  • The Future of Wound Healing: Pain Guard with Brad Wiggins and Dr. Victoria Miles

    The Future of Wound Healing: Pain Guard with Brad Wiggins and Dr. Victoria Miles
    2025/12/26

    In this episode of The PODdoctors podcast, Dr. Damien Dauphinee explores the latest innovations in wound care technology, with a spotlight on SAM (Synthetic Antimicrobial Matrix), a breakthrough solution that integrates lidocaine for effective pain management. Joined by Dr. Victoria Miles and Brad Wiggins from Imbed Biosciences, we discuss how this cutting-edge technology is reshaping burn care and podiatric surgery. The conversation highlights SAM’s dual-action approach, supporting wound healing while delivering meaningful pain relief, leading to improved postoperative outcomes and a reduced reliance on opioid medications.

    Listen as they examine how innovation and evidence-based medicine come together to elevate patient care and improve quality of life.

    Top Takeaways:

    • Introduction to SAM (Synthetic Antimicrobial Matrix) and its role in next-generation wound care
    • How lidocaine integration enhances pain management at the wound site
    • Insights from Dr. Victoria Miles and Brad Wiggins of Embed Biosciences
    • Applications of SAM technology in burn care and podiatric surgery
    • Benefits of a dual-action matrix: accelerated healing and meaningful pain relief
    • Impact on postoperative outcomes and reduced reliance on opioid medications
    • The importance of clinical research and early case studies in validating new technologies
    • Real-world patient experiences demonstrating improved comfort and recovery
    • The future of wound care innovation and its role in improving patient quality of life

    Resources:

    Visit our website: https://thepoddoctors.com/
    続きを読む 一部表示
    41 分
  • Plantar Fibroma

    Plantar Fibroma
    2024/11/08

    In this episode of The PODdoctors podcast, Dr. Damien Dauphinee, a board-certified foot and ankle surgeon, and Dr. Raafae Hussain, a fellowship-trained foot and ankle surgeon, discuss plantar fibromas, benign tumors that form in the plantar fascia of the foot. The doctors discuss the characteristics, causes, and treatment options for these growths, emphasizing that while they can cause discomfort, they are typically not a cause for alarm. The conversation covers various diagnostic methods, including ultrasound and MRI, and explores conservative and surgical treatment approaches. Listeners will gain insights into the importance of addressing these fibromas before they lead to more serious complications, as well as the nuances of surgical intervention when necessary.

    Top Takeaways:

    • The evolution of advanced therapies for diabetic limb preservation showcased a significant increase in treatment options over the last two decades.
    • Plantar fibromas, while often benign, can cause significant discomfort and should be evaluated through careful examination and imaging techniques like ultrasound.
    • Treatment for plantar fibromas often begins conservatively with physical therapy and may escalate to injections or surgical options if necessary.
    • Understanding the potential for benign versus malignant processes is crucial in managing plantar fibromas effectively and safely.
    • The importance of proper post-operative care and rehabilitation after surgical removal of plantar fibromas cannot be overstated for optimal recovery.


    Resources:

    Visit our website: https://thepoddoctors.com/
    続きを読む 一部表示
    16 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません